Medical Industry Innovation Institute

Over the past two decades, the global pharmaceutical market has undergone significant changes. High-priced biopharmaceuticals now dominate top sales,overshadowing Japanese drug discovery, which primarily focuses on small molecule drugs. Japan has found itself sidelined in the race to develop a COVID-19 vaccine, a type of biopharmaceutical, and has had to rely on its own resources. The government has spearheaded efforts to recover from this situation, but the reality is that these efforts are proving to be extremely challenging, with the difficulties seemingly permeating all aspects of Japan’s drug discovery efforts. This forum serves as a gathering place for individuals who remain undeterred by these challenges. These individuals are committed to maximizing the potential of their respective fields through the generous exchange of knowledge, hard work, and financial resources. As we enter a period of significant social and industrial change, this year’s focus will be on the cutting-edge areas that will shape the future of drug discovery. We will also discuss Japan’s role in this field.